Literature DB >> 6978818

A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE.

E Gleichmann, E H Van Elven, J P Van der Veen.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 6978818     DOI： 10.1002/eji.1830120210

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN： 0014-2980            Impact factor:   5.532


× No keyword cloud information.
  72 in total

1.  Non-host cells in the pathogenesis of autoimmune disease: a new paradigm?

Authors:  J L Nelson
Journal:  Ann Rheum Dis       Date:  1999-09       Impact factor: 19.103

Review 2.  Microchimerism and HLA relationships of pregnancy: implications for autoimmune diseases.

Authors:  J L Nelson
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

3.  Cremophor EL as an adjuvant affecting immunoglobulin class switch in the immune response to the thymus-independent antigen alpha(1- greater than 3) dextran B 1355 S.

Authors:  F Austrup; T Kucharzik; E Kölsch
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

4.  Hyperactivity of donor B cells after neonatal induction of lymphoid chimerism in mice.

Authors:  M Goldman; D Abramowicz; P Lambert; P Vandervorst; C Bruyns; C Toussaint
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

5.  The role of autoreactive T-cell hybridomas from autoimmune model mice.

Authors:  S Yanoma; I Aoki; N Ishii; K Tani; C S David; K Okuda
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

6.  Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels.

Authors:  K Ishihara; S Ono; Y Takahama; F Hirayama; H Hirano; K Itoh; K Dobashi; S Murakami; Y Katoh; M Yamaguchi
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

7.  Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus.

Authors:  Charles S Via; Gene M Shearer
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

8.  Qualitative alterations in laminin expression in experimental lupus nephritis.

Authors:  C J Kootstra; E C Bergijk; A Veninga; F A Prins; E de Heer; D R Abrahamson; J A Bruijn
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

9.  Murine monoclonal antibodies to DNA. A comparison of MRL/lpr NZB/W and chronically graft-versus-host-diseased mice.

Authors:  K Brinkman; A van Dam; H van den Brink; R M Termaat; J Berden; R Smeenk
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

10.  Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.

Authors:  J Quddus; K J Johnson; J Gavalchin; E P Amento; C E Chrisp; R L Yung; B C Richardson
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.